Immunomodulatory effects of etanercept in a model of brain injury act through attenuation of the acute-phase response.
TNF-alpha has proved to be a successful target in the treatment of many peripheral inflammatory diseases, but the same interventions worsen immune-mediated CNS disease. However, anti-TNF-alpha strategies may offer promise as therapy for non-immune CNS injury. In this study, we have microinjected IL-...
Main Authors: | Campbell, S, Jiang, Y, Davis, A, Farrands, R, Holbrook, J, Leppert, D, Anthony, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2007
|
Similar Items
-
The systemic and local acute phase response following acute brain injury.
by: Wilcockson, D, et al.
Published: (2002) -
Etanercept attenuates myocardial ischemia/reperfusion injury by decreasing inflammation and oxidative stress.
by: Mei Yang, et al.
Published: (2014-01-01) -
Etanercept
by: Sibel Alper
Published: (2022-04-01) -
CINC-1 is an early hepatic acute phase protein induced by focal brain injury that causes leukocyte mobilization and liver injury
by: Anthony, D, et al.
Published: (2003) -
Etanercept – A culprit agent in acute pancreatitis?
by: Ferry Gunawan, et al.
Published: (2019-03-01)